HCRT and Alzheimer disease: In AD patients, orexinergic neurons are reduced while CSF orexin is often reported to be increased, suggesting a complex, perhaps compensatory, mechanism for dysregulated sleep–wake signals (loss of nighttime sleep and increased daytime napping) [184, 187].